Article
Multidisciplinary Sciences
Shweta Mital, Hai V. Nguyen
Summary: The study found that using procedure-less intragastric balloon (PIGB) as a bridge to bariatric surgery is more cost-effective than undergoing bariatric surgery alone, as it helps achieve a lower post-operative BMI. Additionally, compared to no treatment, using PIGB alone also presents a certain level of cost-effectiveness.
Article
Health Care Sciences & Services
Mohammed A. Bawahab, Khaled S. Abbas, Walid M. Abd El Maksoud, Reem S. Abdelgadir, Khaled Altumairi, Awadh R. Alqahtani, Hassan A. Alzahrani, Muneer Jan Bhat
Summary: This retrospective study aimed to determine the factors affecting weight reduction after intragastric balloon (IGB) insertion. The study found that IGB therapy is a safe and effective option for obesity management, with factors such as age, initial weight and body mass index, duration of IGB insertion, and parity significantly affecting weight loss outcomes. Further larger prospective studies are needed to confirm these results.
Article
Gastroenterology & Hepatology
Federico Salomone, Walter Currenti, Giovanni Magri, Ivo Boskoski, Shira Zelber-Sagi, Fabio Galvano
Summary: This study evaluated the impact of intragastric balloon (IGB) placement in NAFLD patients with advanced fibrosis, showing that IGB can lead to weight loss and reduction in liver stiffness and FIB-4 levels within 6 months. Gastroesophageal reflux symptoms were common, but no severe adverse events were observed.
LIVER INTERNATIONAL
(2021)
Article
Medicine, General & Internal
Francisco Jose Sanchez-Torralvo, Luis Vazquez-Pedreno, Montserrat Gonzalo-Marin, Maria Jose Tapia, Fuensanta Lima, Eduardo Garcia-Fuentes, Pilar Garcia, Javier Moreno-Ruiz, Alberto Rodriguez-Canete, Sergio Valdes, Gabriel Olveira
Summary: Intragastric injection of BT-A is effective for weight loss, especially in extreme obesity. Its use before bariatric surgery enhances perioperative weight loss.
JOURNAL OF CLINICAL MEDICINE
(2022)
Review
Surgery
Lyz Bezerra Silva, Manoel Galvao Neto
Summary: The intragastric balloon is a temporary and minimally invasive therapy for weight loss, mainly for mild obesity. By reducing stomach capacity and inducing decreased hunger and food intake, it effectively promotes weight loss. The development of new devices, such as procedureless and adjustable balloons, offers more options for patients.
MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES
(2022)
Article
Nutrition & Dietetics
Francisco Jose Sanchez Torralvo, Luis Vazquez Pedreno, Montserrat Gonzalo Marin, Maria Jose Tapia, Fuensanta Lima, Eduardo Garcia Fuentes, Pilar Garcia, Javier Moreno Ruiz, Alberto Rodriguez Canete, Sergio Valdes, Gabriel Olveira
Summary: Intragastric injection of botulinum toxin A is an effective and safe procedure to achieve moderate weight loss and improve quality of life for obese patients prior to bariatric surgery.
CLINICAL NUTRITION
(2021)
Article
Gastroenterology & Hepatology
Fateh Bazerbachi, Eric J. Vargas, Monika Rizk, Daniel B. Maselli, Taofic Mounajjed, Sudhakar K. Venkatesh, Kymberly D. Watt, John D. Port, Rita Basu, Andres Acosta, Ibrahim Hanouneh, Naveen Gara, Meera Shah, Manpreet Mundi, Matthew Clark, Karen Grothe, Andrew C. Storm, Michael J. Levy, Barham K. Abu Dayyeh
Summary: In a prospective study, the intragastric balloon (IGB) facilitated significant metabolic and histologic improvements in patients with NASH. The treatment appears to be safe and effective for NASH management when combined with a prescribed diet and exercise program.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
(2021)
Review
Gastroenterology & Hepatology
Yi-An Yen, Chi-Chih Wang, Wen-Wei Sung, Kuan-Chieh Fang, Shih-Ming Huang, Chun-Che Lin, Ming-Chang Tsai, Tzu-Wei Yang
Summary: Intragastric botulinum toxin A (BTA) injection is an effective treatment for obesity, with adequate doses and combined diet control being crucial for its effectiveness.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
(2022)
Article
Medicine, General & Internal
Ghulam Mujtaba, Rida Zehra, Fizra Balkhi, Numra Shaikh
Summary: Non-surgical interventions for weight loss, including the use of Intragastric Balloons (IGBs), are becoming increasingly common. However, complications with IGB insertion are rare. We report a rare case of antral impaction of the IGB, which was successfully removed. Regular follow-ups are essential to prevent serious complications.
JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN
(2022)
Article
Medicine, General & Internal
Laura Akiki, Abdallah Alomary
Summary: The use of intragastric balloons (IGBs) has become increasingly popular for weight loss over the past three decades. Although generally considered effective and safe, there have been reports of complications ranging from mild to severe. This case report highlights a rare occurrence of acute pancreatitis in a patient six months after IGB insertion, which was successfully managed through endoscopic removal of the balloon.
CUREUS JOURNAL OF MEDICAL SCIENCE
(2023)
Article
Surgery
Ricardo Jose Fittipaldi-Fernandez, Idiberto Jose Zotarelli-Filho, Cristina Fajardo Diestel, Marcia Regina Simas Torres Klein, Marcelo Falcao de Santana, Joao Henrique Felicio de Lima, Fernando Santos Silva Bastos, Newton Teixeira dos Santos
Summary: In the analysis of weight loss and complications related to the Spatz3 (R) adjustable intragastric balloon in Brazil, the study showed the treatment to be effective and safe, with no mortality but higher morbidity compared to traditional methods. Further confirmation is needed for the efficacy of the upward adjustment.
Review
Surgery
Saurabh Chandan, Babu P. Mohan, Shahab R. Khan, Antonio Facciorusso, Daryl Ramai, Lena L. Kassab, Neil Bhogal, Ravishankar Asokkumar, Gortrand Lopez-Nava, Stephanie McDonough, Douglas G. Adler
Summary: The systematic review and meta-analysis showed that intragastric balloon (IGB) therapy is effective in improving steatosis, NAFLD activity score (NAS), and HOMA-IR score in patients with NAFLD. Additionally, a significant reduction in liver volume was observed in patients undergoing IGB placement.
Article
Surgery
Umut Firat Turan, Mehmet Kagan Katar, Pamir Eren Ersoy
Summary: The efficacy and safety of intragastric balloon (IGB) application were evaluated, and factors affecting its success were determined. The results showed that IGB application is a relatively effective and safe weight loss treatment, and high BMI and lack of assistance from a dietician are risk factors for failure of IGB.
SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES
(2023)
Article
Surgery
Danielle Abbitt, Adom Netsanet, Alexandra Kovar, Kevin Choy, Teresa S. Jones, Benjamin Cassell, Hazem Hammad, Robert Matthew Reveille, Krzysztof J. Wikiel, Edward L. Jones
Summary: Intragastric balloon placement is safe and effective in achieving preoperative weight loss for patients undergoing elective joint replacement or hernia repair. More than 75% of patients achieved optimal weight and underwent surgery after the use of intragastric balloon.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
(2023)
Article
Gastroenterology & Hepatology
Raed M. Tayyem, Haitham G. Qandeel, Hamzeh Al-Balas, Farah R. Tayyem, Jehad Z. Fataftah, Mahmoud Al-Balas
Summary: In this study, EIBT was found to be a safe and effective treatment for mild obesity. Although the EPGB group showed greater weight loss, the EIBT group had significantly better percentage excess weight loss, procedure duration, postoperative complications, and symptom duration. Quality of life improvement was comparable between the two groups.
SAUDI JOURNAL OF GASTROENTEROLOGY
(2022)
Article
Medicine, General & Internal
Ayseguel Aksan, Dilem Tugal, Nathalena Hein, Katharina Boettger, Yurani Caicedo-Zea, Ina Diehl, Claudia Schumann, Franz-Paul Armbruster, Juergen Stein
JOURNAL OF CLINICAL MEDICINE
(2020)
Letter
Gastroenterology & Hepatology
David Petroff, Olaf Baetz, Katrin Jedrysiak, Jan Kramer, Thomas Berg, Johannes Wiegand
Article
Gastroenterology & Hepatology
Florian Gerhardt, David Petroff, Valentin Blank, Albrecht Boehlig, Florian van Boemmel, Christian Wittekind, Thomas Berg, Thomas Karlas, Johannes Wiegand
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
(2020)
Article
Medicine, General & Internal
Meik Huhn, Martina Herrero San Juan, Balint Melcher, Caroline Dreis, Katrin G. Schmidt, Anja Schwiebs, Janet Collins, Josef M. Pfeilschifter, Michael Vieth, Jurgen Stein, Heinfried H. Radeke
JOURNAL OF CLINICAL MEDICINE
(2020)
Article
Medicine, General & Internal
Philipp Simon, David Busse, David Petroff, Christoph Dorn, Lisa Ehmann, Sophie Hochstaedt, Felix Girrbach, Arne Dietrich, Markus Zeitlinger, Frieder Kees, Charlotte Kloft, Hermann Wrigge
JOURNAL OF CLINICAL MEDICINE
(2020)
Article
Anesthesiology
Felix Girrbach, David Petroff, Susann Schulz, Gunther Hempel, Mirko Lange, Carolin Klotz, Stephanie Scherz, Antonio Giannella-Neto, Alessandro Beda, Alcendino Jardim-Neto, Jens-Uwe Stolzenburg, Andreas W. Reske, Hermann Wrigge, Philipp Simon
BRITISH JOURNAL OF ANAESTHESIA
(2020)
Review
Psychology, Clinical
Anja Hilbert, David Petroff, Stephan Herpertz, Reinhard Pietrowsky, Brunna Tuschen-Caffier, Silja Vocks, Ricarda Schmidt
INTERNATIONAL JOURNAL OF EATING DISORDERS
(2020)
Review
Hematology
Aysegul Aksan, Axel Dignass, Jurgen Stein
EXPERT REVIEW OF HEMATOLOGY
(2022)
Article
Medicine, General & Internal
Eleni Leventi, Ayseguel Aksan, Carl Thomas Nebe, Juergen Stein, Karima Farrag
Summary: The study investigated the diagnostic performance of ZnPP as a reliable biomarker of functional ID in patients with IBD, showing that it is more dependable than ferritin or TSAT in cases influenced by inflammation.
Article
Nutrition & Dietetics
Aysegul Aksan, Izzet Erdal, Siddika Songul Yalcin, Juergen Stein, Gulhan Samur
Summary: The study found that maternal factors such as smoking, BMI, birth route, pregnancy weight gain, and energy intake during lactation are associated with OPN levels in breast milk. The concentration of OPN in breast milk can affect the growth and immune system functions of infants, and is correlated with the body weight, length, head circumference, and febrile hospitalizations of neonates.
Article
Medicine, General & Internal
Johanna Erbach, Florian Bonn, Max Diesner, Anne Arnold, Juergen Stein, Oliver Schroeder, Ayseguel Aksan
Summary: This study found that high serum 3HIVc levels and biotin deficiency were associated with IBD, but not with inflammatory activity. This suggests that biotin may play a role in the pathogenesis of IBD. Routine assessment and supplementation of biotin may help improve IBD and support intestinal health.
JOURNAL OF CLINICAL MEDICINE
(2022)
Letter
Gastroenterology & Hepatology
Heinfried H. Radeke, Juergen Stein
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
(2022)
Article
Surgery
Sarah J. Guenthert, Aysegul Aksan, Oliver Schroeder, Gunther Meyer, Johannes Hausmann, Jurgen Stein, Christine Stier
Summary: Both RYGB and DJBL showed similar remission rates of hyperglycemia after one year in patients with obesity and T2DM, but RYGB induced more significant weight loss compared to DJBL.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
(2022)
Article
Nutrition & Dietetics
Christine Stier, Ann-Cathrin Koschker, Mia Kim, Raphael Stier, Sonja Chiappetta, Juergen Stein
Summary: This study investigated an emergency weight reduction bridging therapy for acutely life-threatening severe obesity. The therapy consisting of liraglutide, amino acid infusion, and hypocaloric diet was found to be effective in achieving technical operability within 2-4 weeks for most patients with severe obesity.
CLINICAL NUTRITION ESPEN
(2022)
Article
Endocrinology & Metabolism
Miriam Oster, Nathalena Hein, Ayseguel Aksan, Heiner Krammer, Sophia Theodoridou, Juergen Stein
Summary: This study compared the efficacy, safety, and cost-effectiveness of the hypocaloric OPTIFAST program with endoscopic intragastric balloon placement for weight loss. The results showed that the OPT group achieved significantly greater weight loss and experienced fewer adverse events compared to the intragastric balloon group.